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Oral intake of a specific extract of Opuntia ficus-indica cladode and fruit skin
(OpunDia™) (OFI) has been shown to increase serum insulin concentration while
reducing blood glucose level for a given amount of glucose ingestion after an
endurance exercise bout in healthy young volunteers. However, it is unknown
whether OFI-induced insulin stimulation after exercise is of the same magnitude
than the stimulation by other insulinogenic agents like leucine as well as whether
OFI can interact with those agents. Therefore, the aims of the present study were:
1) to compare the degree of insulin stimulation by OFI with the effect of leucine
administration; 2) to determine whether OFI and leucine have an additive action
on insulin stimulation post-exercise.
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Abstract
Background: Oral intake of a specific extract of Opuntia ficus-indica cladode and fruit skin (OpunDia™) (OFI) has
been shown to increase serum insulin concentration while reducing blood glucose level for a given amount of
glucose ingestion after an endurance exercise bout in healthy young volunteers. However, it is unknown whether
OFI-induced insulin stimulation after exercise is of the same magnitude than the stimulation by other insulinogenic
agents like leucine as well as whether OFI can interact with those agents. Therefore, the aims of the present study
were: 1) to compare the degree of insulin stimulation by OFI with the effect of leucine administration; 2) to
determine whether OFI and leucine have an additive action on insulin stimulation post-exercise.
Methods: Eleven subjects participated in a randomized double-blind cross-over study involving four experimental
sessions. In each session the subjects successively underwent a 2-h oral glucose tolerance test (OGTT) after a
30-min cycling bout at ~70% VO2max. At t0 and t60 during the OGTT, subjects ingested 75 g glucose and capsules
containing either 1) a placebo; 2) 1000 mg OFI; 3) 3 g leucine; 4) 1000 mg OFI + 3 g leucine. Blood samples were
collected before and at 30-min intervals during the OGTT for determination of blood glucose and serum insulin.
Results: Whereas no effect of leucine was measured, OFI reduced blood glucose at t90 by ~7% and the area under
the glucose curve by ~15% and increased serum insulin concentration at t90 by ~35% compared to placebo
(P<0.05). From t60 to the end of the OGTT, serum insulin concentration was higher in OFI+leucine than in placebo
which resulted in a higher area under the insulin curve (+40%, P<0.05).
Conclusion: Carbohydrate-induced insulin stimulation post-exercise can be further increased by the combination of
OFI with leucine. OFI and leucine could be interesting ingredients to include together in recovery drinks to
resynthesize muscle glycogen faster post-exercise. Still, it needs to be confirmed that such nutritional strategy
effectively stimulates post-exercise muscle glycogen resynthesis.
Keywords: Nutritional supplements, Post exercise recovery, Glucose clearance, Glycogen resynthesis, Endurance
athletes, Amino acids
Background
High-intensity exercise typically leads to a depletion of
body carbohydrate stores, primarily muscle glycogen [1].
Hence high-dose oral carbohydrate intake during recovery
after exercise is pivotal to muscle glycogen resynthesis
and thus repletion of carbohydrate stores [2]. Therefore,
typical sports recovery drinks include a high carbohydrate
dose (~50-100 grams), composed of rapidly absorbable
sugars such as maltodextrin (a D-glucose polymer) and D-
glucose (~dextrose). The increased plasma insulin level
due to high-dose glucose ingestion is pivotal to stimula-
tion of muscle glucose uptake and glycogen synthesis
[3,4]. Insulin, which is secreted by the pancreatic β-cells
upon elevated circulating glucose concentration, stimu-
lates glucose import in muscle cells via the GLUT4 mem-
brane protein. It also stimulates the incorporation of the
glucose molecules into the glycogen molecule via activa-
tion of the glycogen synthase enzyme [5]. In this regard it
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is also important to note that muscular insulin sensitivity
is markedly increased following muscle contractions [6].
Thus, any intervention that could elevate plasma insulin
and/or further increase insulin sensitivity following exer-
cise could facilitate repletion of muscle glycogen stores,
and thus serve as a useful recovery agent.
In this respect, the addition of amino acids, and more
particularly leucine, to a carbohydrate-rich drink is a fre-
quent strategy used by athletes to increase insulin secre-
tion and thereby enhance glycogen resynthesis. Leucine
has a strong insulinotropic action which contributes to a
faster glycogen resynthesis after exercise [7,8]. Based on
recent reports [9,10], Opuntia ficus-indica intake could be
another interesting nutritional strategy to stimulate insulin
secretion and glycogen resynthesis after exercise. Opuntia
ficus-indica is one of the approximately 200 species of the
Opuntia genus, which belongs to the Cactaceae family
[11]. Opuntia ficus-indica has been found to lower blood
glucose and to increase basal plasma insulin levels in ani-
mals [9,12] as well as in humans [10,13,14]. This indicates
a direct action on insulin secretion at the site of pancreatic
β-cells rather than an indirect action via increased blood
glucose levels.
Our group has recently shown that oral intake of a
specific extract of Opuntia ficus-indica cladode and fruit
skin (OFI) increases serum insulin concentration while
reducing blood glucose level for a given amount of
glucose ingestion after an endurance exercise bout in
healthy young volunteers [10]. In a dose–response ex-
periment we also found 1000 mg of OFI to cause a max-
imal increase of plasma insulin concentration. However,
we did not evaluate the interaction of OFI with other
insulinogenic agents like leucine. Moreover, commercial
recovery drinks contain a maximal leucine dose of 3 g
whereas only high doses (~7 g) have been shown to in-
crease carbohydrate-induced insulin stimulation after
exercise [7,8,15]. It is unknown whether lower doses of
leucine increase carbohydrates-induced insulin stimula-
tion as well. Against this background, the aims of the
present study were: 1) to compare the degree of insulin
stimulation by OFI with another prevailing strategy in
sports nutrition to stimulate post exercise insulin re-
lease, i.e. 3 g oral leucine administration; 2) to determine
whether OFI and leucine can have an additive action to
elevate post exercise plasma insulin concentration.
Methods
Subjects
Eleven healthy, physically active males were included in
the study (age: 21.1 ± 0.9 y; body weight: 74.5 ± 4.2 kg;
VO2 max: 65 ± 4 ml·min
-1·kg). After approval of the
study protocol by the local Ethics Committee (KU Leuven),
subjects were asked to give their written consent after they
were informed of all experimental procedures and risks
associated with the experiments. Furthermore, they were
submitted to a medical screening before being enrolled in
the study. Subjects who had any pathology or were taking
any medication or nutritional supplements that were not
compatible with the study protocol were excluded. All pro-
cedures were carried out in accordance with the Declar-
ation of Helsinki (2000) of the World Medical Association.
Preliminary testing
Two weeks before the start of the study, the subjects
performed a maximal incremental exercise test (initial
load 60 Watts (W) + 35 W per 3 min) on a bicycle erg-
ometer (Avantronic Cyclus II, Leipzig, Germany) to de-
termine the rate of maximal oxygen uptake (VO2max)
and the corresponding workload. Heart rate (Polar,
Kempele, Finland), VO2 and VCO2 (Cortex Metalyzer II,
Leipzig, Germany) were continuously measured during
the test.
Study protocol
A double–blind randomized cross-over study was per-
formed. Subjects participated in four experimental ses-
sions with a 1-week interval in between. Subjects
abstained from any high intensity exercise for 48 hours
prior to the experiments. In the evening before the
experimental sessions, subjects received a standardized
carbohydrate-rich dinner (860 kcal, 73% carbohydrates,
14% fat, 13% protein), after which they remained fasted.
On the morning of the experiments they reported to the
laboratory in the fasted state between 8:00 and 9:00a.m.
to perform a 30-min endurance exercise bout at 70% of
their previously determined VO2max at a cadence fixed at
90-100 rpm. At the end of the exercise the subjects got
seated in a comfortable armchair and an intravenous
catheter was inserted into an arm vein for repeated blood
sampling during the experiment after which a baseline
blood sample was collected. The subjects received cap-
sules containing either: 1) LUVOS Heilerde serving as
placebo (PL); 2) 1000 mg Opuntia ficus-indica cladode
and fruit skin extract (OFI) (OpunDia™, Finzelberg,
Germany); 3) 3 g leucine (LEU) (Ajinomoto, Japan); 4)
1000mg Opuntia ficus-indica extract + 3 g leucine (OFI+
LEU). All capsules had identical appearance and the num-
ber of capsules ingested was the same for each condition.
OpunDia™ is a preferred blend of Opuntia ficus-indica
cladode and fruit skin extract containing 75% cladode ex-
tract and 25% fruit skin extract (for both extraction solv-
ent: water; DER (drug-to-extract ratio) 2–4:1; 50% native
extract, 50% collagen hydrolysate as excipient). All plant
materials of Opuntia ficus-indica were obtained from a US
American-based cultivation having breeding experience
since 1923 [16]. Voucher specimens of the drug material
are deposited at PhytoLab, Vestenbergsgreuth, Germany.
The dose of 1000 mg OFI was selected based on
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preliminary dose–response data showing 1000 mg to be
the lowest dose needed to maximally increase plasma
insulin concentration [10]. After ingestion of the sup-
plement together with a 75 g glucose bolus in 300 ml
water, a 2-hr oral glucose tolerance test (OGTT) was
started at time 0 (t0). Thereafter, a blood sample (5 ml)
was collected from the arm vein catheter into vacuum
tubes containing Silica clot activator (BD Vacutainer,
NJ, USA), at 30, 60, 90, and 120 min. During the OGTT,
an additional dose of OFI (1000 mg) and/or LEU (3 g),
together with glucose (75 g), was given at t60 to main-
tain blood glucose concentration high. Blood samples
were centrifuged (1500 rpm for 15 min at 4°C) to spin
down the serum which was stored at −80°C until ana-
lyzed at a later date for insulin.
Blood samples
Serum insulin was assayed by chemiluminescence using
the Siemens DPC kit and according to the instructions
by the manufacturer. Blood glucose concentration was
determined on 10 μl blood coming from the earlobe
using an automated micro-analyzer (Arkray Inc., Kyoto,
Japan).
Data calculations and statistical analyses
The positive incremental area under the glucose curve
and the insulin curve were calculated as previously
described [17,18]. The differences between the condi-
tions (PL, OFI, LEU and OFI+LEU) were analyzed by
Student’s paired T-tests using the SigmaPlot® statistical
software package. A probability level of P≤0.05 was con-
sidered statistically significant. All data are expressed as
means ± SE.
Results
OFI and leucine have an additive insulinogenic effect
All subjects tolerated the supplements well and none
exhibited symptoms of gastrointestinal distress. Post ex-
ercise blood glucose concentration was 4.0 ± 0.1 mmol/l
in all experimental conditions (Figure 1A). Thirty mi-
nutes following the initial 75 g glucose bolus together
with the supplement(s), blood glucose peaked at 6.6 ±
0.1 mmol/l, to gradually decrease thereafter. Compared
with PL, OFI reduced blood glucose at t90 by 7% (5.7 ±
0.2 in OFI vs 6.2 ± 0.3 mmol/l in PL, P<0.05, Figure 1A)
and the area under the 2-h glucose curve by about 15%
(190 ± 24 in OFI vs 233 ± 33mmol/l/2h in PL, P<0.05,
Figure 1B). Leucine tended to decrease blood glucose
concentration at t90 (P=0.070, Figure 1A). Post exercise
serum insulin concentration was 5.7 ± 0.6 mU/l and
reached 35-50 mU/l during the OGTT depending on the
treatment. From t60 to the end of the OGTT, serum insulin
concentration was higher in OFI+LEU than in PL (P<0.05,
Figure 1C). OFI alone increased insulin concentration only
Figure 1 Effect of Opuntia ficus-indica cladode and fruit skin extract and/or leucine on blood glucose and serum insulin during a post
exercise OGTT. Concentrations of blood glucose (A) and serum insulin (C), as well as the calculated area under the curve for blood glucose (B)
and serum insulin (D) during a 120-min OGTT after exercise and after having ingested a placebo (PL), Opuntia ficus-indica cladode and fruit skin
extract (OFI), leucine (LEU) or Opuntia ficus-indica cladode and fruit skin extract + leucine (OFI+LEU). Data are means ± SE (n=11). *P<0.05 vs PL.
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at t90 (50 ± 10 in OFI vs 36 ± 7 mU/l in PL, P<0.05). Ac-
cordingly, OFI+LEU increased by about 40% (4555 ± 923
in OFI+LEU vs 3259 ± 663 mU/l/2h in PL, P<0.05) and
OFI alone tended to increase (4272 ± 761 in OFI vs 3259 ±
663 mU/l/2h in PL, P=0.059) the area under the insulin
curve (Figure 1D). Leucine had no effect on insulin
concentration.
Discussion
In a recent study, we showed for the first time that OFI
can elevate circulating plasma insulin concentration dur-
ing high rate carbohydrate ingestion in humans at rest
and after exercise [10]. This finding is particularly rele-
vant to endurance athletes seeking to restore high
muscle glycogen concentration between training sessions
so as to maintain training quality [19]. As muscle glyco-
gen repletion is sensitive to insulin [3], most promin-
ently during the initial hours following an exercise bout
[20,21], it is important for athletes to establish high cir-
culating plasma insulin concentrations during early re-
covery following a strenuous training. It is of note that
muscle insulin sensitivity is enhanced after exercise,
which facilitates glycogen resynthesis compared with rest
[6]. High rate carbohydrate ingestion, up to 1.0-1.2 g/kg/h
for a few hours, is the prevailing nutritional strategy to in-
crease glucose delivery to muscles together with elevated
plasma insulin concentration and thereby stimulate glyco-
gen resynthesis [7,22]. Adding proteins to a carbohydrate
load will even speed up glycogen repletion due to the
insulinogenic action of proteins and more particularly due
to the branched-chain amino acid leucine [7,8,15]. Adding
0.4 g casein hydrolysate/kg/h to a drink containing 0.8 g
carbohydrates/kg/h more than doubled plasma insulin re-
sponse compared with only the carbohydrates. Insulin re-
sponse was even tripled when 0.1 g leucine/kg/h was
added to the carbohydrates/casein hydrolysate drink [15].
Similar results were obtained previously, but in those earl-
ier studies both leucine and phenylalanine were added to
the supplements, which makes it impossible to isolate the
actions of the two amino acids [7,8]. In the study by
Kaastra [15], drinks were not isoenergetic, which may ac-
count for the difference in plasma insulin concentration.
However, when drinks were prepared to be isocaloric, car-
bohydrates combined with proteins still induced a higher
insulin response than carbohydrates alone [7]. Contrary to
those previous studies, our results do not show a clear
additional insulinogenic effect of leucine when co-ingested
with a high amount of carbohydrates. We deliberately
chose a dose of 3 g of leucine instead of ~ 7 g (0.1 g/kg)
by others [7,8,15] because leucine has a very low palatabil-
ity, and therefore most commercial sports supplements
contain a maximum of 3 g leucine. We also based our de-
cision on a recent report showing that 3.42 g leucine
alone, in the absence of carbohydrate intake and at rest,
increased plasma insulin concentration by 50% within
30 min before returning to basal levels [23]. It is thus pos-
sible that the smaller amount of leucine, compared to
previous studies, added to the high amount of glucose
(~1 g/kg/h) was not large enough to further enhance
plasma insulin concentration in the present study.
Based on our data, 1000 mg OFI had a slightly higher
insulinogenic action than 3 g leucine, certainly 30 min
after ingestion of the glucose + OFI beverage. OFI seems
to stimulate insulin production acutely and rapidly as
serum insulin concentrations during the OGTT each time
were increased 30 min after OFI ingestion but no more 60
min after OFI intake. The insulinogenic action of OFI thus
clearly is short-lived. The largest effect on plasma insulin
concentration was obtained by the combined ingestion of
OFI plus leucine. Indeed, insulin concentration was per-
sistently elevated during the second hour of the OGTT
when OFI and leucine were administered together. In
addition, a trend (P=0.09) to increase in insulin concentra-
tion was observed in OFI + LEU compared with OFI alone
at 60 and 120 min. As blood glucose concentrations were
not modified by OFI plus leucine, the increase in insulin
did not result from higher blood glucose levels. Our re-
sults rather indicate that OFI and leucine directly stimu-
late pancreatic insulin release, and that the effects of both
agents are additive. Whereas the physiological mechanism
by which OFI facilitates glucose-induced pancreatic insu-
lin release remains to be elucidated, it is known that leu-
cine increases pancreatic β-cell insulin secretion through:
1) its oxidative decarboxylation; 2) its ability to allosteri-
cally activate glutamate dehydrogenase, and 3) its trans-
amination to α-ketoisocaproate [24]. Those events will
subsequently lead to an increased tricarboxylic acid-cycle
flux, an increased ATP/ADP ratio, the closure of the
ATP-sensitive potassium channels, a depolarization of the
plasma membrane and the opening of the calcium sen-
sitive channels which will finally cause the secretion of
insulin [25-27]. Whether OFI increases the tricarboxylic
acid-cycle flux in beta-cells as well, or whether it depolar-
izes the membrane via a different mechanism than leucine
remains to be investigated.
The combination of OFI with leucine seems the best
option to increase plasma insulin concentrations after
exercise and thereby to potentially accelerate glycogen
resynthesis. Nevertheless we did not measure any differ-
ence in the area under the glucose curve when both
treatments were given together compared to placebo,
which could indicate that muscle glucose uptake prob-
ably is not substantially modified by combined OFI plus
leucine administration. Blood glucose concentration dur-
ing an OGTT reflects the equilibrium between the rate
of glucose appearance from the gut and liver, and the
rate of disappearance through peripheral glucose uptake.
It can be hypothesized that OFI combined with leucine
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actually increased both processes that resulted in un-
changed blood glucose concentrations. However, this is
not likely to be the case as the addition of amino acids
to a carbohydrate-rich drink was previously shown to
decrease the rates of appearance and disappearance of
blood glucose instead [15]. As the decreases were equal
in amplitude, it was suggested that amino acids-induced
insulin stimulation accelerates glycogen resynthesis after
exercise by increasing glycogen synthase activity rather
than by increasing muscle glucose uptake [15]. Further
studies should try to determine whether the higher cir-
culating insulin levels established by combined OFI plus
leucine administration together with high rate glucose
uptake post exercise, effectively translate into higher
glycogen synthase activity and glycogen resynthesis rate
following exercise.
Conclusion
Carbohydrate-induced insulin stimulation after exercise
can be further increased by the combination of Opuntia
ficus-indica cladode and fruit skin extract with leucine.
In the perspective of developing optimal nutritional
strategies to recover muscle glycogen faster after high-
intensity endurance exercise, OFI and leucine could be
interesting ingredients to include together in recovery
drinks. Still, it needs to be confirmed that such nutri-
tional strategy effectively stimulates post exercise muscle
glycogen resynthesis.
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